Table S3.
Study | Initial PK | Tolerability |
Dose, mg⋅kg | 20 | 50 |
Administration | Single dose | Seven doses, SID |
Cmax, ng⋅mL; nM | 1,140 ± 72.1; 1,951 ± 123 | 1,275 ± 359; 2,182 ± 614 |
Tmax, h | 1.7 ± 1.15 | 2 ± 0 |
T1/2, h | 3.86 ± 0.28 | 16.78 ± 4.73 |
AUC0–24, h⋅ng⋅mL−1 | 12,050 ± 982 | 21,476 ± 4,087 |
Cl, mL⋅min⋅kg−1 | 27.2 ± 2.24 | 22.83 ± 4.09 |
Vd, L⋅kg | 9.11 ± 1.21 | 33.41 ± 8.2 |
MRT, h | 9.09 ± 1.33 |